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        3-Amino-1,2,4-benzotriazine di-N-oxide (tirapazamine, TPZ) belongs to a new class of anti-tumor
drugs and requires bio-reductive activation for its medicinal properties.  Tirapazamine derives anti-tumor
properties from its ability to cause DNA damage in oxygen poor conditions found in solid tumors.  However,
the exact DNA damaging agent produced from activated TPZ is still a matter of debate. 
        In our studies, we investigated into the exact nature of DNA damaging agent(s) produced from
activated TPZ and its related di-N-oxide compounds.  As part of our mechanistic studies we carried out
DNA cleavage assays, isotopic labeling studies and radical trapping experiments.  Our data shows that TPZ
and its related di-N-oxide compounds upon bio-reductive activation produce known DNA damaging agent
hydroxyl radical.  Thus, our results suggest that TPZ and its structurally related heterocyclic di-N-oxides
deliver known radiotherapeutic DNA damaging agent hydroxyl radical especially in oxygen poor
environment found in solid tumors.
